These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 27693579)
1. The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice. Omede A; Zi M; Prehar S; Maqsood A; Stafford N; Mamas M; Cartwright E; Oceandy D Biochem Biophys Res Commun; 2016 Oct; 479(4):708-714. PubMed ID: 27693579 [TBL] [Abstract][Full Text] [Related]
2. Leucine zipper protein 1 attenuates pressure overload-induced cardiac hypertrophy through inhibiting Stat3 signaling. Fan D; Jiang WL; Jin ZL; Cao JL; Li Y; He T; Zhang W; Peng L; Liu HX; Wu XY; Chen M; Fan YZ; He B; Yu WX; Wang HR; Hu XR; Lu ZB J Adv Res; 2024 Sep; 63():117-128. PubMed ID: 37806546 [TBL] [Abstract][Full Text] [Related]
3. SENP1 Protects Against Pressure Overload-Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling. Yang D; Fan D; Guo Z; Liu FY; Wang MY; An P; Yang Z; Tang QZ J Am Heart Assoc; 2022 Nov; 11(22):e027004. PubMed ID: 36370010 [TBL] [Abstract][Full Text] [Related]
4. Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN/AKT pathway. Yang H; Wang XX; Zhou CY; Xiao X; Tian C; Li HH; Yin CL; Wang HX J Cell Mol Med; 2020 Jun; 24(11):6233-6241. PubMed ID: 32343488 [TBL] [Abstract][Full Text] [Related]
5. C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress. Zhang B; Zhang P; Tan Y; Feng P; Zhang Z; Liang H; Duan W; Jin Z; Wang X; Liu J; Gao E; Yu S; Yi D; Sun Y; Yi W Cell Death Dis; 2019 Jul; 10(7):520. PubMed ID: 31285424 [TBL] [Abstract][Full Text] [Related]
6. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload. Zhou N; Ma B; Stoll S; Hays TT; Qiu H Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247 [TBL] [Abstract][Full Text] [Related]
7. The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy. Meng C; Su H; Shu M; Shen F; Lu Y; Wu S; Su Z; Yu M; Yang D Cell Death Dis; 2024 Sep; 15(9):683. PubMed ID: 39294131 [TBL] [Abstract][Full Text] [Related]
8. Transactivated EGFR mediates α₁-AR-induced STAT3 activation and cardiac hypertrophy. Li Y; Zhang H; Liao W; Song Y; Ma X; Chen C; Lu Z; Li Z; Zhang Y Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1941-51. PubMed ID: 21856923 [TBL] [Abstract][Full Text] [Related]
9. Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice. Lee KN; Lu X; Nguyen C; Feng Q; Chidiac P J Mol Cell Cardiol; 2017 Jul; 108():194-202. PubMed ID: 28641980 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms. Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648 [TBL] [Abstract][Full Text] [Related]
11. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling. Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234 [TBL] [Abstract][Full Text] [Related]
12. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload. Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822 [TBL] [Abstract][Full Text] [Related]
13. Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice. Liu Y; Jiang XL; Liu Y; Jiang DS; Zhang Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H Cardiovasc Res; 2014 Jan; 101(1):87-96. PubMed ID: 24285748 [TBL] [Abstract][Full Text] [Related]
14. Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway. Yuan L; Qiu L; Ye Y; Wu J; Wang S; Wang X; Zhou N; Zou Y J Cell Mol Med; 2018 Sep; 22(9):4292-4303. PubMed ID: 29992755 [TBL] [Abstract][Full Text] [Related]
15. Yak OXGR1 promotes fibroblast proliferation via the PI3K/AKT pathways. Wang Q; Zhang Q; Zhang Y; Zhao X J Cell Biochem; 2019 Apr; 120(4):6729-6740. PubMed ID: 30520130 [TBL] [Abstract][Full Text] [Related]
16. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure. Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233 [TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis. Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543 [TBL] [Abstract][Full Text] [Related]
18. TNIP3 protects against pathological cardiac hypertrophy by stabilizing STAT1. Shi H; Yu Y; Li D; Zhu K; Cheng X; Ma T; Tao Z; Hong Y; Liu Z; Zhou S; Zhang J; Chen Y; Zhang XJ; Zhang P; Li H Cell Death Dis; 2024 Jun; 15(6):450. PubMed ID: 38926347 [TBL] [Abstract][Full Text] [Related]
19. MG53, A Novel Regulator of KChIP2 and I Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025 [TBL] [Abstract][Full Text] [Related]
20. STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy. Li PL; Liu H; Chen GP; Li L; Shi HJ; Nie HY; Liu Z; Hu YF; Yang J; Zhang P; Zhang XJ; She ZG; Li H; Huang Z; Zhu L Hypertension; 2020 Oct; 76(4):1219-1230. PubMed ID: 32862709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]